Another Regeneron Bear is Born By: Stocks to Watch October 20, 2017 at 15:57 PM EDT Shares of Regeneron are falling today after an analyst at Barclays warned that expectations surrounding the eczema drug Dupixent are too high. Here's why. Read More >>